Flibanserin can be safely added to a stable SSRI or SNRI regimen to treat hypoactive sexual desire disorder.
Men, including male physicians, are less likely than female physicians to seek medical treatment for their own health conditions.
Flibanserin may improve some measures of sexual dysfunction in premenopausal women.
A clinician should also rule out the possibility that the dysfunction stems from a co-occurring medical or psychiatric condition, or substance abuse.
Awareness of adolescents' sexual history is essential in providing mental health treatment.
Researchers found that the brains of those with compulsive sexual behaviors "lit up" in the same way as drug addicts' brains.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Sertraline Effective for Treating Depression in Vascular Cognitive Impairment
- Hospitalization Rates in Schizophrenia—Lurasidone vs Quetiapine
- Ketamine-Induced Dissociative Symptoms Predict Antidepressant Response
- First Nonopioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Review Examines the Effectiveness of Antidepressants for Insomnia
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- Antidepressant Use May Be Linked With Sustained Risk for Weight Gain
- Language Used in Medical Record Can Affect Patient Care
- Family History of Psychiatric Disorders an Important Predictor of Postpartum Psychiatric Illness
- Increased Risk for Type 2 Diabetes in Adolescents, Young Adults With ADHD
- Worse Cognitive Outcomes Associated With CMV Antibodies Following ART for HIV